About
Previsedx offers Esopredict, a methylation-based diagnostic test that stratifies risk for progression from Barrett’s esophagus to high-grade dysplasia or esophageal adenocarcinoma by analyzing DNA methylation markers and patient age.
Explore Previsedx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.